May 20, 2011
A U.N. Conference on Trade and Development report issued last week suggested "[l]ocal production of pharmaceuticals in some poor African and Asian countries, such as Ethiopia, Uganda, and Bangladesh, has the potential to improve access to essential drugs for many of the one billion people who live in the world's least developed countries," BMJ News writes. The report notes that local pharmaceutical manufacturing development must focus on public health, and investment in the sector "would boost the prospects to manufacture locally cheaper generic medicines to treat a range of infectious illness such as HIV/AIDS, malaria, and neglected tropical diseases, as well as chronic diseases such as diabetes, hypertension, and cancers" (Zarocostas, 5/18).
Back to other news for May 2011
This information was reprinted from kff.org with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.

This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
|
No comments have been made.
|